Cargando…
Vasodilator-stimulated phosphoprotein (VASP) is not a major mediator of platelet aggregation, thrombogenesis, haemostasis, and antiplatelet effect of prasugrel in rats
Vasodilator-stimulated phosphoprotein (VASP) is a member of actin regulatory proteins implicated in platelet adhesion. In addition, phosphorylation of VASP is utilised for the assessment of platelet reactivity in patients treated with P2Y(12) receptor antagonists, a class of antiplatelet agents. How...
Autores principales: | Ito, Yusuke, Ohno, Kousaku, Morikawa, Yuka, Tomizawa, Atsuyuki, Mizuno, Makoto, Sugidachi, Atsuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028634/ https://www.ncbi.nlm.nih.gov/pubmed/29967338 http://dx.doi.org/10.1038/s41598-018-28181-8 |
Ejemplares similares
-
Prasugrel, a Platelet P2Y(12) Receptor Antagonist, Improves Abnormal Gait in a Novel Murine Model of Thrombotic Hindlimb Ischemia
por: Ohno, Kousaku, et al.
Publicado: (2016) -
A Novel Model of Intravital Platelet Imaging Using CD41-ZsGreen1 Transgenic Rats
por: Mizuno, Makoto, et al.
Publicado: (2016) -
Phosphorylation of Vasodilator-Stimulated Phosphoprotein (VASP) Dampens Hepatic Ischemia-Reperfusion Injury
por: Köhler, David, et al.
Publicado: (2011) -
The role of vasodilator-stimulated phosphoprotein (VASP) in the control of hepatic gluconeogenic gene expression
por: Tateya, Sanshiro, et al.
Publicado: (2019) -
Antiplatelet Effect of Single Antiplatelet Therapy With Prasugrel and Oral Anticoagulation After Stent Implantation in a Rabbit Arteriovenous Shunt Model
por: Torii, Sho, et al.
Publicado: (2021)